Delivery Order 36F79719D0160-36C26023F0042
Award Date
11/1/22
Potential Completion Date
10/31/23
Potential Value
$133K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Catalyst Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $203,147 delivery order to Catalyst Pharmaceuticals, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Catalyst Pharmaceuticals will supply AMIFAMPRIDINE FIRDAPSE 10MG tablets to various VA facilities in Veterans Integrated Service Network 20. Performance will take place in Bartlett, Tennessee over a one year base period from November 1, 2023 through October 31, 2024. Pricing is firm fixed. This...
This federal contract award to Catalyst Pharmaceuticals, Inc., doing business as Catalyst Pharmaceuticals, is for the delivery of the pharmaceutical product AMIFAMPRIDINE (FIRDAPSE) 10MG. The contract, valued at $18,526.09, was awarded by the Department of Veterans Affairs (VA) and its Veterans Health Administration (VHA) network. It is a firm fixed-price delivery order placed against Catalyst's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has no set-aside...
Catalyst Pharmaceuticals, Inc. was awarded a $29,691.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the delivery of amiFAMPRIDINE 10MG tablets to a location in Miami, Florida, with performance required by December 19, 2021. The order was placed off GSA Schedule FSS-61-IB, which provides pharmaceuticals and drugs to federal...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $154,859.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Catalyst Pharmaceuticals, Inc. for the provision of 10mg Firdapse (amifampridine) tablets. The order is for a firm fixed price and has a period of performance through October 31, 2022. The Pharmaceuticals and Drugs schedule, managed by GSA, provides government agencies access to...
The Department of Veterans Affairs Veterans Health Administration awarded a $16,928.97 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. Catalyst Pharmaceuticals, Inc. will provide the pharmaceutical products under its Pharmaceuticals and Drugs GSA Schedule contract with the General Services Administration. Performance will take place in Bartlett, Tennessee from December 6-8, 2023. The funding agency, VA-VHA Network 5, will utilize the products to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $30,608.30 firm fixed price delivery order contract to Catalyst Pharmaceuticals, Inc. for the medication FIRDAPSE. The contract has no set-aside designation and is to be completed by March 13, 2019, with Catalyst Pharmaceuticals performing as the prime contractor. As the award is for a specific medication, it can be inferred this supports the VA's mission to provide healthcare...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,080.48 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and place of performance in Miami, Florida. No set-aside designation was used for this award to the prime contractor Catalyst Pharmaceuticals for the branded drug to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with performance at a facility in Bartlett, Tennessee. No set-aside designation was used for this order to supply the anti-neuromuscular drug Firdapse to support VHA healthcare programs in the...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The $861,948.00 contract is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease symptoms. The contract is placed under Acorda's Federal Supply Schedule (FSS) contract with the VA, which is valued at over $16.3 million and allows the VA to procure Acorda's pharmaceutical...